Literature DB >> 4914614

A comparative study of three hypnotics: methyprylon, glutethimide and chloral hydrate.

W T Brown.   

Abstract

A controlled study designed to evaluate the hypnotic potentiality of methyprylon (300 mg.), glutethimide (500 mg.) and chloral hydrate (1000 mg.) was carried out on 50 in-patients experiencing long-standing insomina. The patients ranged in age from 21 to 60 years, the sexes were equally represented and the clinical diagnoses were psychoneurosis, reactive depression, or anxiety reaction. An interesting feature of the experimental design allowed for the exclusion of placebo reactors before the initiation of the main trials. No difference in effectiveness of maintaining sleep could be established among the three hypnotic agents, indicating that at the usual levels of statistical significance, all three agents were equally effective as hypnotics. However, a significant trend (P = .05) was found for methyprylon (Noludar) to be the most effective and chloral hydrate to be the least effective of the three drugs in maintaining sleep. Methyprylon was found statistically (P = .05) to be the fastest sleep-inducing agent, whereas glutethimide (Doriden) proved to be the slowest of the three hypnotics with respect to sleep induction time.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4914614      PMCID: PMC1946598     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  A comparative controlled clinical trial of seven hypnotic agents in medical and psychiatric in-patients.

Authors:  K RICKELS; H BASS
Journal:  Am J Med Sci       Date:  1963-02       Impact factor: 2.378

2.  Comparative clinical study of two hypnotic drugs.

Authors:  T A BAN; K McGINNIS
Journal:  Can Med Assoc J       Date:  1962-10-13       Impact factor: 8.262

  2 in total
  1 in total

Review 1.  Therapeutic assessment of chloral hydrate premedication for pediatric dentistry.

Authors:  P A Moore
Journal:  Anesth Prog       Date:  1984 Sep-Oct
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.